AI assistant
Victrex PLC Director's Dealing 2021
5290_dirs_2021-12-16_fd122b06-1e1b-471f-80b1-a1a833a35642.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 9288V
Victrex PLC
16 December 2021
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
| a) | Name | Martin Court | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Executive Director (PDMR) | |||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | Victrex plc | |||
| b) | LEI | 213800UYNPHAUNHPXL67 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument | Ordinary shares of 1p each | |||
| Identification code | GB0009292243 | ||||
| b) | Nature of the transaction | Exercise of 15,556 nil cost options granted 8 December 2016 under the Victrex plc 2009 Long Term Incentive Plan, which comprised of 1,006 shares being made up of a net hypothetical dividend amount. Exercise of 2,154 nil cost options granted 10 December 2018 under the Victrex plc 2017 Deferred Bonus Plan, which comprised of 108 shares being made up of a net hypothetical dividend amount. Dr Court sold sufficient shares 7,824 arising from the exercise to cover costs, and retained the balnce as shares. |
|||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) sold | Volume retained | |||
| £23.8375 | 7,824 | 9,886 | |||
| d) | Aggregated information | ||||
| - Aggregated volume exercised - No of shares retained |
17,710 9,886 |
||||
| - Price | £23.8375 | ||||
| e) | Date of the transaction | 2021-12-15 | |||
| f) | Place of the transaction | Thornton, Cleveleys, Lancaire |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHGZMMZFVKGMZM